[TOVX] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[TOVX] Theriva Biologics, Inc.
Announcement Date
30-Jun-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -14.89%
YoY- -55.24%
Quarter Report
TOVX's Result
TOVX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -8,316 -5,443 -4,968 -3,195 -2,883 -3,558 -4,214 11.98%
Tax 0 -359 -8 0 -16 -27 -806 -
NP -8,316 -5,084 -4,960 -3,195 -2,867 -3,531 -4,197 12.06%
Tax Rate - - - - - - - -
Total Cost 8,316 5,084 4,960 3,195 2,867 3,531 4,197 12.06%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.43 -8.38 -0.31 -0.24 -1.56 -2.14 -11.39 -42.05%
EPS Diluted -10.72 -8.38 -0.31 -0.24 -1.56 -2.14 -11.39 -1.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.